Abstract 3065: High-throughput screen identifies HSP90 as a potential therapeutic target in models of advanced CRPC
Keith H. Jansson(National Cancer Institute), Kathleen Kelly(National Cancer Institute), Crystal Tran(National Cancer Institute), Michael L. Beshiri(National Cancer Institute), Eva Corey(University of Washington), John B. Tucker(University of Wisconsin–Madison), Ross Lake(National Cancer Institute), Lauren E. Stahl(National Cancer Institute), Paul G. Hynes(National Cancer Institute), David A. Proia(C4 Therapeutics (United States)), Jacob Cawley(National Cancer Institute), Rajarshi Guha(Vertex Pharmaceuticals (United States)), Caitlyn Fuller(National Cancer Institute), Lei Fang, Supreet Agarwal(University of Iowa), Aian Neil Alilin(National Cancer Institute), John K. Simmons(University of Pittsburgh), Xiaohu Zhang(Soochow University), R. Mark Simpson(National Institutes of Health), Shelley Hoover, Holly M. Nguyen(University of Washington), JuanJuan Yin(National Cancer Institute), Craig J. Thomas(National Institutes of Health)
Cited by 0
Related Papers
Increased demand for NAD+ relative to ATP drives aerobic glycolysis
|Molecular Cell|2020|561
The Blue Obelisk—Interoperability in Chemical Informatics
|Journal of Chemical Information and Modeling|2006|396
Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|391
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
|Cancer Discovery|2017|336